Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination
Unique ID
C017323
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C017323
Entry Term(s)
Fluosol DA-20
Fluosol-DA
glucose - glycerol - hydroxyethyl starch - perfluorodecalin - perfluorotripropylamine - pluronic F-68 - salts - yolk phospholipids
Pharm Action
Contrast Media
Radiation-Sensitizing Agents
Registry Numbers
75216-20-5
0
CAS Type 1 Name
Fluosol DA
Heading Mapped to
Drug Combinations
*Fluorocarbons
*Hydroxyethyl Starch Derivatives
Frequency
375
Note
contains perfluorodecalin, perfluorotripropylamine, pluronic F-68, yolk phospholipids, glycerol, salts, glucose, hydroxyethyl starch
Source
JAMA 1980;243(8):719
JAMA 1980;243(8):721
Jpn J Anesthesiol 27(7):717;1978
Kokyu To Junkan 1979;27(8):869
Masui 1979;28(9):929
Indexing Information
Blood Substitutes
Plasma Substitutes
Date of Entry
1979/01/01
Revision Date
2014/10/27
glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination Preferred
Fluosol DA-20 Narrower
Fluosol-DA Narrower
page delivered in 0.005s